Objective: To determine trends in late-onset neonatal infections and risk factors for ampicillin/penicillin-resistant microorganisms.
Introduction
Intrapartum antibiotic prophylactic (IAP) treatment for group B Streptococcus (GBS) positive mothers became the standard of practice in the late 1990s. Since that time, studies have emerged finding an increasing incidence of non-GBS pathogens in neonatal sepsis. Multiple studies reported an increased incidence of earlyonset infections caused by Gram-negative bacteria, specifically Escherichia coli (E. coli) [1] [2] [3] [4] [5] and an increased incidence in antibiotic-resistant pathogens, specifically ampicillin resistant E. coli. [5] [6] [7] [8] [9] The findings vary across studies and are specific to the preterm or very low-birthweight (VLBW) populations. [3] [4] [5] [6] [7] Less investigation has been focused on the patterns of causative microorganisms and antibiotic resistance among late-onset infections (infections occurring at 8 to 30 days of age) over time. The institution of IAP treatment resulted in a 70% reduction in the incidence of early-onset neonatal GBS infections in the United States 10 and subsequently more than half of neonatal GBS infections now occur in the late-onset period. 11, 12 Concerns have been raised that the widespread use of IAP could have unintentional consequences on late-onset infections, such as causing a delay in the presentation of GBS disease, thus resulting in an increase in late-onset GBS infections. 12, 13 The incidence of late-onset GBS infections has remained stable since the early 1990's, suggesting universal screening and IAP treatment of GBS positive mothers has little to no effect on late-onset GBS disease. 10,12 -14 Our study hypothesis was that the causative pathogens and antibiotic resistance seen in late-onset neonatal infections are not affected by the use of IAP treatment. We examined late-onset infections in both term and preterm populations over an 18-year period. We broadened the scope of neonatal infections to include not only bloodstream infections but also documented infections in cerebrospinal fluid and urine. Our goal was to identify the causative pathogens and resistance patterns of late-onset neonatal infections over time, and to evaluate potential risk factors for any changes identified.
Methods

Study design
Data on all positive blood, urine and cerebrospinal fluid cultures from infants 8 to 30 days of age, collected between 1 January 1990 and 31 December 2007, at a large, regional tertiary care center were obtained from the hospital's microbiology laboratory database. Cultures were collected from inpatient units, including the neonatal and pediatric intensive care units (NICU, PICU), newborn nursery, inpatient ward, and the emergency room and ambulatory clinics. Exclusionary criteria were if the positive culture was a virus, from an outpatient visit that did not result in a hospital admission, or interpreted as a contaminant by the treating physician. Outborn infants treated for positive cultures obtained at the referring hospital were not included, due to lack of full microbiologic data. The study was approved by the hospital's institutional review board.
Data were collected from linked infant and maternal charts and included demographic characteristics, infant location at time of culture, intrapartum and neonatal risk factors, maternal and infant antibiotic exposures, infant risk factors for infection and hospital outcomes. Data from the microbiology database included the microorganism identified, date the specimen was collected, source of the culture and antibiotic susceptibilities. Two study investigators performed ongoing data cleaning and verification, with 3% of the data double-collected for quality assurance.
The 18-year study period was divided into three epochs, based on the hospital's IAP practices, with infants grouped into epochs based on their birth year: Epoch 1, 1990 to 1995, before formal IAP guidelines; Epoch 2, 1996 to 2002, when IAP was primarily riskfactor-based and Epoch 3, 2003 to 2007, when IAP was based on universal screening. During the span of the study period, ampicillin and gentamicin were used as first-line therapies for initial sepsis evaluations. Third-generation cephalosporins were used only as additive therapy for specific indications or treatment failures.
Definitions
Infants were classified as having a late-onset infection if they had a positive culture at 8 to 30 days of age. A culture was included in the study if, after reviewing the medical record, the treating physician at the time of initial infection documented the infection and treated it as such, regardless of the microorganism, source, colony count or method of collection for urine cultures. Multiple positive cultures were grouped as one infection episode if the causative microorganism was the same within the same time period. In these cases, antibiotic resistance was coded as the most resistant within the episode.
Intrapartum antibiotic therapy was defined as any antimicrobial agent administered from the onset of labor until the time of delivery, with intrapartum GBS prophylaxis being the specific use of penicillin or ampicillin. Prolonged rupture of membranes was defined as rupture for X18 h. Maternal infection was defined as the presence of maternal fever, fetal tachycardia during labor or placental pathology confirming chorioamnionitis.
Statistical analysis
Demographic data, infection rates, causative pathogens and rates of ampicillin/penicillin resistance were compared across epochs. For analysis, missing birthweights (<2% of data) were imputed as the mean gestational age-specific birthweight of that particular epoch, and missing maternal ages (<5% of data) were imputed as the mean maternal age within that epoch.
Continuous variables were analyzed using ANOVA; w 2 test was used to compare dichotomous variables. We could not determine the incidence of late-onset infections for all infants, because the study population drew from a larger group than just inborn infants. Therefore, incidence was calculated using the VLBW sample (infants with birthweights <1500 g), based on total VLBW admissions. A multivariable logistic regression model was built to identify independent predictors of ampicillin/penicillin resistance. Adjusted ORs were calculated for each covariate. To account for the violation of independence of observations, because the unit of analysis was cultures and not infants, a generalized estimating equation was used for the regression analysis. A p-value of <0.05 was considered significant. Data were analyzed with SPSS 16.0 (IBM, Armonk, NY, USA).
Results
The study was performed at a large, urban referral hospital, which serves a broad geographical area. During the study years, there were an average of 2500 deliveries and 600 to 700 NICU admissions per year, with 30% being outborn.
The hospital's microbiology laboratory database identified 1188 infants with a positive culture at 8 to 30 days of age. Of these infants, only 584 met study criteria ( Trends in late-onset neonatal infections KL Ecker et al culture was deemed a contaminant by the treating physician and not treated with a length of treatment appropriate for that specific source/microorganism. The majority of the excluded cultures were from the urine, and coagulase-negative Staphylococcus species was the predominant pathogen deemed a contaminant from all culture sources. There were significant increases in the use of prenatal steroids, intrapartum antibiotics and detection of maternal GBS over time (specifically between Epoch 1 vs Epoch 2), all related to changes in clinical practice. As a result of changing clinical practice, there were fewer unknowns in the maternal documentation. There were significant differences in the number of mothers with preterm labor and prolonged rupture of membranes, but these likely reflect a decrease in the number of unknowns in later epochs. Changes in regional population demographics resulted in an increase of 'other' maternal races (non-African American, non-Caucasian), and the age of mothers also significantly increased over time (Table 1) . Other demographic data examined but not found to be significant over epochs included the use of antibiotics during pregnancy and maternal infections. Placental pathology confirming chorioamnionitis represented 70% of the positive maternal infections.
Across epochs, there was a significant increase in the number of infants diagnosed with late-onset infections who required surgery or had central lines during their hospitalization. This finding, however, did not hold for those infants requiring surgery for necrotizing enterocolitis alone. The increased use of central lines reflects the increasing use of percutaneous venous catheters over time. The chronological age of the infant at the time of initial infection varied significantly over epochs, as did gender of the infants. The majority of cases of late-onset infections occurred in hospitalized infants rather than in infants seen in other ambulatory sites. There were no significant differences in gestational age, birthweight or outcomes (Table 2) .
There were 615 late-onset infection episodes in 584 infants. Figure 1 shows the distribution of the sources of infections. Candidal infections represented an increased percentage of total infections over the epochs (P ¼ 0.006), with an increased incidence of candidal infections seen among VLBW infants (Epoch 1: 7.42 cases per 1000 VLBW admissions; Epoch 2: 22.42 cases per 1000 VLBW admissions; Epoch 3: 24.29 cases per 1000 VLBW admissions; P ¼ 0.014). A significant rise in the incidence of Gram-negative infections in the VLBW sample also occurred (Epoch 1: 11.66 cases per 1000 VLBW admissions; Epoch 2: 22.42 cases per 1000 VLBW admissions; Epoch 3: 35.51 cases per 1000 VLBW admissions; P ¼ 0.009).
Increased ampicillin resistance was seen only among late-onset E. coli infections (specifically Epochs 2 and 3, compared with Epoch 1) (P ¼ 0.006) ( Table 3) . Risk factors for ampicillin/ penicillin resistance among late-onset infections were evaluated using a multivariable logistic regression analysis. Only the use of intrapartum ampicillin or penicillin was found to be a significant independent risk factor for antibiotic resistance (OR: 2.05; 95% Variables included in the model but not found to be significant were: maternal age, race, gravida and GBS status; prolonged rupture of membranes, preterm labor, gender and birthweight, antibiotics given to the infant at birth, day of life the positive culture occurred, central lines, chronic lung disease and any surgeries required. In additional regression analysis, mortality was not associated with antibiotic resistance. Antibiotic resistance did not correlate with other measures of morbidity such as chronic lung disease or need for surgery.
Discussion
Our study hypothesis was that IAP practices have no impact on the epidemiology of causative pathogens or antibiotic-resistance patterns in late-onset neonatal infections. Our findings, however, did not support our hypothesis. Because this study included outborn infants originating from a large number of birth hospitals, we were unable to determine the birth rates inclusive of this large referral population, and thus unable to report incidence for the entire population or to discuss any change in the rates of late-onset infections as a whole across epochs. The VLBW sample, for which a denominator was known, was used to determine changes in incidence over time. We found an increasing number of candidal infections in the study population over time, along with an increase in ampicillin resistance among late E.coli infections over the study period. In the VLBW sample, there was an increased incidence in both candidal infections and Gram-negative infections over time. Additionally, the use of intrapartum ampicillin or penicillin was an independent predictor for ampicillin/penicillin resistance among late-onset infections. 
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It is well-documented that intrapartum antibiotic prophylaxis has dramatically reduced early-onset neonatal GBS sepsis, however, the impact of IAP use on late-onset infections has not been wellcharacterized. Some studies have investigated the impact of IAP use on GBS specifically, concluding IAP has had no effect on late GBS infections. 12, 13 However, there has been increasing erythromycin and clindamycin resistance among GBS isolates, 10, 14, 15 and a few reports have shown reduced susceptibility to penicillin in GBS isolates, although to date, the incidence of this resistance remains very limited. 16, 17 Lingering concerns remain regarding an increase in the incidence of non-GBS infections and the emergence of antibiotic resistance among those pathogens. Because of these concerns, this study was designed to review our own institution's trends in lateonset neonatal infections, with attention to patient demographics and practice variability. Previous studies examining late-onset infections have been focused primarily on bacteremia, so to capture the complete infection burden experienced by neonates over time, we included blood, urine and cerebrospinal fluid infections in this study.
Our study found an increased incidence of late-onset Gramnegative infections over epochs, other than E. coli, in the VLBW sample. Other studies have also noted an increase in late Gramnegative infections, 1, 8 with Bizzarro et al. 5 finding an increase specifically in late-onset E. coli infections. Although the incidence of E. coli infections was not increased at our institution, there was a significant increase in ampicillin resistance among the late-onset E.coli infections. This finding may be related to the complexity of the infants who developed late-onset infections in our study. Increasing ampicillin resistance among Gram-negative pathogens in late-onset infections, but not specifically E. coli, has been previously reported. 18 The use of intrapartum ampicillin/penicillin increased the risk twofold for antibiotic resistance among late-onset infections. Typically, intrapartum antibiotics affect early-onset infections, which result from vertical transmission, with less-expected impact on late-onset infections, whose acquisition is through horizontal transmission. Our findings may reflect an impact of intrapartum antibiotics on the microorganisms that colonize these high-risk infants, particularly those with ongoing medical complications. Because late-onset infections are common complications in infants who are hospitalized, investigating longitudinal evaluation of hospitalized infants beyond 30 days of life, particularly those in the NICU, is needed to evaluate the contribution of hospital risk factors, in addition to ongoing antibiotic exposure.
The proportion of late-onset infections caused by Candida increased over time, with a significant increase in the incidence of fungal infections in the VLBW sample. This increase in candidal infections in relation to the initiation of GBS prophylaxis has not been previously reported, with Fridkin et al. 19 actually showing a decrease in the incidence within a similar time period. Benjamin et al. 20 found antenatal antibiotics to be a risk factor for invasive candidiasis in extremely low birthweight infants, but did not report on incidence or the specific use of GBS prophylaxis. Several studies have reported on risk factors for the development of neonatal candidal infections, which have included low birthweight, low gestational age, bronchopulmonary dysplasia, postnatal steroid use, as well as central catheters, broad-spectrum antibiotic exposure, intravenous lipid emulsion, thrombocytopenia and endotracheal tubes. [20] [21] [22] The increased use of prenatal steroids and the increased complexity of our infants, reflected in the increased number of central lines and surgeries over the epochs, may also explain our findings.
Regardless of changing microorganisms or antibiotic resistance in neonatal sepsis, morbidity and mortality rates remain significant. Infection is a risk for mortality from any cause and in analyzing our overall mortality, not just those deaths associated with the specific infection, our study's mortality rate of 10 to 12% in infants with late-onset infections is lower than most previously published reports. To control for bias of urinary tract infections alone, a secondary analysis was performed without urine cultures, yielding similar percentages. Studies have shown mortality rates as high as 40%, 5, 23, 24 and suggest that increased mortality rates depend on the causative pathogen 8, 23, 24 or antibiotic-resistant pathogens. 25 Despite changes in microorganisms and antibiotic resistance over epochs in our study population, we did not find any differences in the mortality rates over time. Additionally, mortality was not associated with antibiotic resistance in regression analysis.
The strength of our epidemiologic review of late-onset infection pathogens arises from the long time span of 18 years, which permits the control of variability in yearly infection rates and which illuminates the impact of changing clinical practice. We also broadened the scope by examining multiple sources of infection to account for the true infection burden in the neonatal population. Additionally, all infants, not just those admitted to the NICU, have been included. This study's limitations are that the distribution of the population among epochs was skewed and individual epoch sample size was small because epoch length was determined by clinicalpractice changes. The referral nature of our institution may affect the study population because of the high-risk maternal population and complex infant population. The majority of the infections are in hospitalized infants, so this may not adequately reflect infants in an outpatient setting. Also, this study was a retrospective chart review; missing data and the need to interpret past clinical decisions may have influenced the results. Despite these limitations, we showed significant differences in the causative pathogens, specifically in the VLBW population, and in E.coli ampicillin resistance among epochs.
This study suggests that changes in both pathogens causing late-onset neonatal infections and patterns of antibiotic resistance are likely multifactorial. The use of intrapartum antibiotics for GBS prophylaxis did increase the risk for antibiotic resistance, but likely highlights an at-risk population and may be serving as a marker for other factors or the complexity of the cases. Exposure to intrapartum antibiotics and the complications encountered during the hospital course should be considered when selecting antibiotics for the treatment of late-onset infections, while awaiting culture results. Antibiotic resistance did not impact morbidity or mortality rates. A rise in late neonatal candidal infections has been noted, which requires further investigation.
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